Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH) With Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT05644717
What this trial is testing

Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD

Who this might be right for
Liver FatLiver FibrosisGlycemic Control+3 more
Getz Pharma 164
Testing effectiveness (Phase 2)Study completedNCT03449446
What this trial is testing

Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 395
Not applicableUnknownNCT04281303
What this trial is testing

Endoscopic Bariatric Therapy in NASH Cirrhosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Instituto de Investigación Marqués de Valdecilla 10
Large-scale testing (Phase 3)Ended earlyNCT03053050
What this trial is testing

Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 808
Testing effectiveness (Phase 2)Study completedNCT01694849
What this trial is testing

Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)
Genfit 275
Not applicableUnknownNCT06111859
What this trial is testing

Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification

Who this might be right for
Liver Disease ChronicFibrosis, LiverLiver Steatoses+4 more
King's College Hospital NHS Trust 180
Large-scale testing (Phase 3)UnknownNCT05605158
What this trial is testing

Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
Tanta University 56
Not applicableActive Not RecruitingNCT05256979
What this trial is testing

Ursodeoxycholic Acid in Patients With NAFLD - Clinical Observation

Who this might be right for
Non-Alcoholic Fatty Liver Disease
General University Hospital, Prague 20
Large-scale testing (Phase 3)Looking for participantsNCT06632444
What this trial is testing

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis (MASH)Liver Fibrosis
Boehringer Ingelheim 1,800
Not applicableNot Yet RecruitingNCT07793279
What this trial is testing

Hypothyroidism and Liver Fibrosis Severity in MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHypothyroidismLiver Cirrhosis+1 more
Assiut University 85
Not applicableLooking for participantsNCT05720663
What this trial is testing

Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
Virginia Commonwealth University 240
Testing effectiveness (Phase 2)Study completedNCT02466516
What this trial is testing

Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)
Gilead Sciences 72
Testing effectiveness (Phase 2)Study completedNCT05364931
What this trial is testing

Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

Who this might be right for
Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
AstraZeneca 54
Testing effectiveness (Phase 2)Study completedNCT03912532
What this trial is testing

Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
NGM Biopharmaceuticals, Inc 171
Testing effectiveness (Phase 2)WithdrawnNCT04607655
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Galecto Biotech AB
Large-scale testing (Phase 3)Looking for participantsNCT06215716
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

Who this might be right for
NASH With FibrosisMASH With Fibrosis
Akero Therapeutics, Inc 1,650
Not applicableLooking for participantsNCT05330923
What this trial is testing

Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic SteatohepatitisFibrosis+1 more
Peking Union Medical College Hospital 2,000
Early research (Phase 1)Ended earlyNCT05864391
What this trial is testing

Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH.

Who this might be right for
Steatohepatitis
AstraZeneca 40
Large-scale testing (Phase 3)Study completedNCT01791959
What this trial is testing

The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
National Nutrition and Food Technology Institute 54
Testing effectiveness (Phase 2)Study completedNCT02279524
What this trial is testing

A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH

Who this might be right for
Fatty LiverNon-Alcoholic SteatohepatitisLiver Diseases+1 more
Galmed Research and Development, Ltd. 247
Next Page